Pipeline Catalysts
The latest news about Pipeline Catalysts: headlines, AI summaries and the full story from every source.
- JPMorgan Upgrades Biogen to Overweight with $300 Price Target on Strong Pipeline Catalysts in 2027
- Regeneron Reports Strong Performance from EYLEA HD, Dupixent Growth, and Upcoming Pipeline Catalysts
- Agios Pharmaceuticals Q1 Earnings Report and Pipeline Updates
- Citi Raises AstraZeneca Earnings Forecast and Maintains 'Buy' Rating Ahead of Second-Half Pipeline Catalysts